Fulgent Genetics, Inc. (FLGT)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$15.33
-1.73%
Mkt Cap $485.18M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | $85.38M | $83.34M | -2.39% | $0.03 | $0.16 | +433.33% | — | — |
| Q4 2025 Nov 7, 2025 | $85.38M | $84.07M | -1.54% | -$0.24 | $0.14 | +158.33% | — | — |
| Q3 2025 Aug 1, 2025 | $81.43M | $81.80M | +0.46% | -$0.23 | $0.07 | +130.43% | — | — |
| Q2 2025 May 2, 2025 | $76.98M | $73.46M | -4.57% | -$0.19 | $0.04 | +121.05% | — | — |
| Q1 2025 Feb 28, 2025 | $75.39M | $76.21M | +1.09% | -$0.31 | $0.04 | +112.90% | — | — |
| Q4 2024 Nov 8, 2024 | $75.39M | $71.74M | -4.84% | -$0.19 | $0.31 | +263.16% | — | — |
| Q3 2024 Aug 2, 2024 | $69.07M | $71.03M | +2.83% | -$0.31 | $0.15 | +148.39% | — | — |
| Q2 2024 May 3, 2024 | $65.36M | $64.48M | -1.34% | -$0.33 | -$0.01 | +96.97% | — | — |
| Q1 2024 Feb 28, 2024 | $66.32M | $70.50M | +6.31% | -$0.30 | $0.28 | +193.33% | — | — |
| Q4 2023 Nov 3, 2023 | $67.14M | $84.69M | +26.13% | -$0.33 | -$0.39 | -18.18% | — | — |
| Q3 2023 Aug 4, 2023 | $62.48M | $67.85M | +8.60% | -$0.33 | -$0.08 | +75.76% | — | — |
| Q2 2023 May 5, 2023 | $60.05M | $66.17M | +10.19% | -$0.45 | -$0.22 | +51.11% | — | — |
| Q1 2023 Feb 28, 2023 | $59.57M | $67.70M | +13.66% | -$0.56 | -$0.48 | +14.29% | — | — |
| Q4 2022 Nov 7, 2022 | $91.36M | $105.66M | +15.65% | $0.17 | $0.32 | +88.24% | — | — |
| Q3 2022 Aug 4, 2022 | $122.70M | $125.34M | +2.15% | $0.73 | $0.78 | +6.85% | — | — |
| Q2 2022 May 3, 2022 | $270.85M | $320.27M | +18.25% | $3.86 | $5.08 | +31.61% | — | — |
| Q1 2022 Feb 23, 2022 | $191.10M | $251.67M | +31.70% | $2.61 | $3.34 | +27.97% | — | — |
| Q4 2021 Nov 9, 2021 | $131.96M | $227.87M | +72.68% | $3.25 | $3.95 | +21.54% | — | — |
| Q3 2021 Aug 9, 2021 | $153.62M | $153.62M | +0.00% | $2.76 | $2.47 | -10.51% | — | — |
| Q2 2021 May 6, 2021 | $318.95M | $359.43M | +12.69% | $5.86 | $6.59 | +12.46% | — | — |